Reuter H - Search Results

1

Bleeding and thrombosis outcomes in hospitalised COVID-19 patients on low-molecular-weight heparin and antiplatelet therapy.

Pillay-Fuentes Lorente V, Van Rensburg R, Moolla MS, McCaul M, Parker A, Taljaard J, Reuter H, Decloedt EH. Pillay-Fuentes Lorente V, et al. Among authors: reuter h. S Afr Med J. 2022 Jul 1;112(7):472-477. S Afr Med J. 2022. PMID: 36217857

2

Benefit v. risk when using chloroquine in patients with severe COVID-19 disease.

Decloedt EH, Reuter H, Allwood B, Parker A, Koegelenberg CFN, Blockman M, Taljaard J. Decloedt EH, et al. Among authors: reuter h. S Afr Med J. 2020 Apr 2;110(5):12903. doi: 10.7196/SAMJ.2020.v110i5.14761. S Afr Med J. 2020. PMID: 32657706 No abstract available.

3

Ivermectin for COVID-19: Promising but not yet conclusive.

Van Rensburg R, Decloedt EH, Reuter H, Parker A, Schrueder N, Lahri S. Van Rensburg R, et al. Among authors: reuter h. S Afr Med J. 2021 Jan 12;111(3):13187. doi: 10.7196/SAMJ.2021.v111i3.15522. S Afr Med J. 2021. PMID: 33944732 Free article. No abstract available.

4

Ivermectin exposures reported to the Poisons Information Helpline in South Africa during the COVID-19 pandemic.

Pillay-Fuentes Lorente V, Voigt G, Du Plessis CE, Balme K, Marks CJ, Decloedt EH, Stephen C, Reuter H, Van Rensburg R. Pillay-Fuentes Lorente V, et al. Among authors: reuter h. S Afr Med J. 2022 Aug 2;112(8):522-525. doi: 10.7196/SAMJ.2022.v112i8.16473. S Afr Med J. 2022. PMID: 36214394

5

Psychopathology and coping in recently diagnosed HIV/AIDS patients--the role of gender.

Olley BO, Gxamza F, Seedat S, Theron H, Taljaard J, Reid E, Reuter H, Stein DJ. Olley BO, et al. Among authors: reuter h. S Afr Med J. 2003 Dec;93(12):928-31. S Afr Med J. 2003. PMID: 14750493

6

Incident tuberculosis disease in patients receiving biologic therapies in the Western Cape, South Africa from 2007 to 2018.

du Toit T, Esterhuizen TM, Tiffin N, Abulfathi AA, Reuter H, Decloedt EH. du Toit T, et al. Among authors: reuter h. BMC Infect Dis. 2020 Nov 30;20(1):900. doi: 10.1186/s12879-020-05624-0. BMC Infect Dis. 2020. PMID: 33256634 Free PMC article.

7

Development of active tuberculosis in patients treated with biological disease-modifying antirheumatic drugs.

Strong J, Mann TN, Tarr GS, Reuter H. Strong J, et al. Among authors: reuter h. S Afr Med J. 2022 Feb 1;112(2):13498. S Afr Med J. 2022. PMID: 35139986

8

The use of adenosine deaminase and interferon-gamma as diagnostic tools for tuberculous pericarditis.

Burgess LJ, Reuter H, Carstens ME, Taljaard JJ, Doubell AF. Burgess LJ, et al. Among authors: reuter h. Chest. 2002 Sep;122(3):900-5. doi: 10.1378/chest.122.3.900. Chest. 2002. PMID: 12226030

9

Drug concentration at the site of disease in children with pulmonary tuberculosis.

Lopez-Varela E, Abulfathi AA, Strydom N, Goussard P, van Wyk AC, Demers AM, Deventer AV, Garcia-Prats AJ, van der Merwe J, Zimmerman M, Carter CL, Janson J, Morrison J, Reuter H, Decloedt EH, Seddon JA, Svensson EM, Warren R, Savic RM, Dartois V, Hesseling AC. Lopez-Varela E, et al. Among authors: reuter h. J Antimicrob Chemother. 2022 May 29;77(6):1710-1719. doi: 10.1093/jac/dkac103. J Antimicrob Chemother. 2022. PMID: 35468189 Free PMC article.

10

Clinical Pharmacokinetics and Pharmacodynamics of Rifampicin in Human Tuberculosis.

Abulfathi AA, Decloedt EH, Svensson EM, Diacon AH, Donald P, Reuter H. Abulfathi AA, et al. Among authors: reuter h. Clin Pharmacokinet. 2019 Sep;58(9):1103-1129. doi: 10.1007/s40262-019-00764-2. Clin Pharmacokinet. 2019. PMID: 31049868 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

648 results

Search Page

Filters